510(k) Report

510(k) · Cleared

Cleared

XBody Go USA, XBody Pro USA

K242926510(k) TraditionalCleared May 30, 2025248-day reviewClass II21 CFR 890.5850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Xbody Hungary Kft. · NGX Stimulator, Muscle, Powered, For Muscle Conditioning

Cleared on May 30, 2025 as substantially equivalent to K221200 (Xbody Hungary Kft., 2023) after a 248-day review. Its family tree reaches back 5 generations to 1994.

Decided
May 30, 2025
Review
248 days
Class
Class II
Product code
NGX
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K940301 (1994). No later device cites it as a predicate yet.

  1. Root · 5 generations backK940301 Compex 2Biodex Medical Systems, Inc. · 1994
  2. 4 generations backK011880 Compex SportCompex S.A. · 2002
  3. 3 generations backK133225 E-Fit EF-1280 Ems MachineFit-Pro Kft, Ltd. · 2014
  4. 2 generations backK190038 Xbody Newave USAXbody Hungary Kft. · 2019
  5. 1 generation backK221200 XBody Go USA, XBody Pro USAXbody Hungary Kft. · 2023
  6. This deviceK242926 XBody Go USA, XBody Pro USAXbody Hungary Kft. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K940301Compex 2Biodex Medical Systems, Inc.1994—
−4K011880Compex SportCompex S.A.2002—
−3K133225E-Fit EF-1280 Ems MachineFit-Pro Kft, Ltd.2014—
−2K190038Xbody Newave USAXbody Hungary Kft.2019—
−1K221200XBody Go USA, XBody Pro USAXbody Hungary Kft.2023—
0 (this device)K242926XBody Go USA, XBody Pro USAXbody Hungary Kft.2025—
FIG. 1 — Lineage of K242926, 1994–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NGX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NGX device

  1. #1 K250146 SofWave Systemscore 15.5 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K221200XBody Go USA, XBody Pro USA
Summary page 5
…te Device Predicate Device: XBody Go USA, XBody Pro USA Manufacturer: XBody Hungary Kft Predicate 510(k) Number: K221200 1 XBody Hungary Kft.…
Xbody Hungary Kft.2023—

Also cleared against K221200: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 31 years and passes through 4 companies; a new generation was cleared every 4.4 years on median.
  • None of the 5 ancestors has a recall.
  • 1 other device also cites its predicate K221200.

How does its category compare?

All NGX devices

NGX Stimulator, Muscle, Powered, For Muscle Conditioning: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · NGX

15in 2025

2007: 72008: 32009: 42010: 62011: 52012: 32013: 62014: 62015: 92016: 42017: 102018: 62019: 142020: 112021: 122022: 62023: 122024: 122025: 152026 (partial year): 4
2007high 15 (2025) · low 3 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NGX

93in 2025

2007: 135 days median2008: 209 days median2009: 132 days median2010: 180 days median2011: 291 days median2012: 362 days median2013: 269 days median2014: 298 days median2015: 184 days median2016: 240 days median2017: 108 days median2018: 104 days median2019: 167 days median2020: 207 days median2021: 256 days median2022: 307 days median2023: 96 days median2024: 207 days median2025: 93 days median2026 (partial year): 118 days median
2007high 362 (2012) · low 93 (2025)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NGX

2in 2013

2013: 2
2007high 2 (2013) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · NGX

15in 2025

2011: 12013: 12015: 72016: 212017: 22018: 62019: 42020: 72021: 52022: 72023: 82024: 112025: 15
2007high 21 (2016) · low 0 (2007)2025

MAUDE reports naming product code NGX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007713500
2008320900
2009413200
2010618000
2011529101
2012336200
2013626921
2014629800
2015918407
20164240021
20171010802
2018610406
20191416704
20201120707
20211225605
2022630707
2023129608
202412207011
20251593015
202641180—

What is it indicated for?

The XBODY Go USA and XBODY Pro USA are machines with electronic muscle stimulation based on EMS technology. The devices are specifically designed as an addition to other sports and for training muscles. They must be used only for healthy muscles and clients, not for rehabilitation purposes. Both models are intended to stimulate healthy muscles in order to improve or facilitate muscle performance. Neither model is intended to be used in conjunction with…

Read the full statement (226 words)

The XBODY Go USA and XBODY Pro USA are machines with electronic muscle stimulation based

on EMS technology. The devices are specifically designed as an addition to other sports and for

training muscles. They must be used only for healthy muscles and clients, not for rehabilitation

purposes.

Both models are intended to stimulate healthy muscles in order to improve or facilitate muscle

performance. Neither model is intended to be used in conjunction with therapy or treatment of

medical diseases or medical conditions of any kind. None of the XBODY Go USA or XBODY Pro

USA training programs are designed for injured or ailing muscles and their use on such muscles is

contraindicated.

For both models, electrical impulses allow the triggering of action potentials on motoneurons of

motor nerves (excitations). These excitations of motoneurons are transmitted to the muscle fibers

via the motor endplate where they generate mechanical muscle fiber responses that correspond to

muscle work. Depending on the parameters of the electrical impulses (pulse frequency, duration of

contraction, duration of rest, total session duration), different types of muscle work can be imposed

on the stimulated muscles.

The various types of muscle work that the XBODY Go USA and XBODY Pro USA can impose on

the stimulated muscles are able to improve or facilitate muscle performance. Both models may

therefore be considered a technique of muscle training.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K242926: XBody Go USA, XBody Pro USA.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K242926

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026